Pfizer Inc
(NYSE: PFE)
▼
34.32
-0.27
-0.78%
1 Day
Open
34.44
Volume (Avg)
24.39M (28.48M)
52Wk Range
27.51-34.97
Top Stories
-
Kahn Brothers’ Top Picks to Close 2014, as Founder Irving Kahn Passes at 109
INSIDER MONKEY 2 days ago -
Pfizer laments narrow recommendation for meningitis vaccine
Reuters 3 days ago -
Pfizer Becomes #4 Most Shorted Dow Stock, Replacing DuPont
Forbes 3 days ago -
A Look Behind the Bedroom Door at What's Causing Your Low Libido
The Huffington Post 3 days ago -
Is Valeant Pharmaceuticals Inc. a Soaring Rocket or a Hot Air Balloon?
The Motley Fool 4 days ago -
Pharmacyclics Weighs Sale of $15 Billion U.S. Drugmaker
Bloomberg 4 days ago
-
Court dismisses case accusing Pfizer Australia of anti-competitive conduct
theguardian.com 4 days ago -
Pfizer Australia Lipitor Case Dismissed
NASDAQ 4 days ago -
Form 4 PFIZER INC For: Feb 23 Filed by: DAMELIO FRANK A
StreetInsider 5 days ago -
Stocks to Watch: Comcast, Home Depot, Macy’s
The Wall Street Journal 5 days ago -
Pfizer Meningitis B Vaccine Meets Safety, Tolerability Goals in Studies
Wall Street Journal 5 days ago -
Sanofi names CEO, cites 'capability to unite teams'
Reuters 2/20/2015
-
Hot Dividend Stocks: Pfizer Pulls Back Into Buy Range
Investors Business Daily 2/19/2015 -
Has Pfizer Inc. Finally Solved Its Immuno-oncology Problem?
The Motley Fool 2/18/2015 -
Pfizer Announces FDA Acceptance for Review of NDA for ALO-02
Benzinga 2/13/2015 -
Pfizer Announces FDA Acceptance for Review of a New Drug Application for ALO-02 (oxycodone hydrochloride and naltrexone hydrochloride)
Benzinga 2/13/2015 -
Will Pfizer Inc. Look to Buy Valeant Pharmaceuticals Intl Inc.?
The Motley Fool 2/10/2015 -
Will Pfizer Inc. Break Up in 2015?
The Motley Fool 2/10/2015
-
Pfizer To Buy Hospira At A Premium Of More Than 100% Above Its Intrinsic Value
Seeking Alpha 2/10/2015 -
Pfizer in $5 billion accelerated buyback deal with Goldman, Sachs & Co
Reuters 2/10/2015 -
Pfizer in $5 billion accelerated buyback deal with Goldman, Sachs & Co
The Business Insider 2/10/2015 -
Pfizer in $5 billion accelerated buyback deal with Goldman, Sachs & Co
Reuters 2/9/2015 -
Pfizer Commences $5 Billion Accelerated Share Repurchase
Investors Business Daily 2/9/2015 -
Pfizer's Acquisition Of Hospira Looks Good
Seeking Alpha 2/9/2015
-
Will Pfizer (PFE) Stock Be Helped Today by This Analyst Upgrade?
The Street 2/9/2015 -
Dow Jones (DJIA) Today: Pfizer (PFE) Higher
The Street 2/6/2015 -
Lipitor inventor takes aim at cholesterol again
theday.com 18 hrs ago -
New Drug Approvals - The Month That Was
Realtime Business News 19 hrs ago -
Health Beat: Senior Wellness Education Series continues
Suffolk Times 1 day ago -
February M&A Confirms Big Pharma Deals Still In Vogue
Law 360 2 days ago
-
UTHealth’s Belinda Reininger Recognized for Excellence in Public Health Practice
News Wise 2 days ago -
Examining Block Trading Activity and Options for Pfizer (PFE)
AVAFIN 2 days ago -
New York Stock Exchange's 10 most active stocks at 1 p.m.
Fox Business 2 days ago -
Ceritinib (Zykadia) Recommended for Approval in EU
Medscape News 2 days ago -
Pfizer Mercifully Puts Down Another Batch Of Trial Patients
The Onion 2 days ago -
Cortendo Announces Proposed Changes to Board of Directors
VentureBeat 2 days ago
-
Morning Recap : Twitter, Inc. (TWTR), Pfizer Inc. (PFE), Rite Aid Corporation (RAD), Monster Beverage Corporation (MNST), CSX Corp. (CSX)
wallstreetscope.com 2 days ago -
Top-line results positive for Pfizer’s TRUMENBA Phase 2 study
Vaccine News Daily 2 days ago -
Pfizer, Inc., Novartis AG Criticize CDC’s Recommendation For Meningitis B Vaccines
bidnessetc.com 2 days ago -
Two New London business recognized by city
theday.com 2 days ago -
The 5 NYSE Stocks With the Highest Short Interest in February
24/7 Wall ST 3 days ago -
Pfizer, Novartis say meningitis vaccine scope too narrow
Channel News Asia 3 days ago
-
CDC Advisory Committee on Immunization Practices Votes to Recommend Serogroup B Meningococcal Disease Vaccination for Persons at Increased Risk
Business Wire 3 days ago -
Pfizer : demolition takes toll on Groton grand list
4 Traders 3 days ago -
High Volume Stocks Today – GE, BAC, BIOC, PFE, S, FB, F, CLRX, JCP, BSX
Fx Pips 3 days ago -
Gilead avoids billions in taxes on expensive drugs
San Francisco Gate 3 days ago -
What is CRISPR? Drug Developers Harness The New Genome Editing Tool; But Can It Deliver Novel Drugs?
International Business Times 3 days ago -
Pfizer reports positive results from phase 2 study of Trumenba with MCV4 & Tdap vaccines
Pharmabiz 3 days ago
-
Global Strongyloidiasis Therapeutics Clinical Trials Market H2 2014 Review Research Report
New Jersey Online 4 days ago -
Excelera Specialty Pharmacy Network named as a specialty-distribution outlet for select Pfizer products
Virtual-Strategy Magazine 4 days ago -
FDA moves on superbugs, Pfizer’s R&D shrinks and no one is ready if Obamacare crumbles (Morning Read)
MedCity News 4 days ago -
Pfizer court win on Lipitor a blow for ACCC
The Australian 4 days ago -
Pfizer plans to cut research jobs in Cambridge
The Business Journal 4 days ago -
Irregular Moves: Pfizer Inc. (NYSE:PFE), Merck & Co. Inc. (NYSE:MRK), Johnson & Johnson (NYSE:JNJ)
emarketsdaily.com 4 days ago
-
Trumenba meningitis B vaccine study shows good results
outbreaknewstoday.com 4 days ago -
Nigeria: Stanbic Ibtc Holding Appoints Directors
AllAfrica 4 days ago -
PBMC Health receives $15K Grant from Pfizer and the Avon Foundation for Women to Support Patients Living With Metastatic Breast Cancer
Riverhead Local 5 days ago -
Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference
Market Watch 5 days ago -
Acute Renal Failure (Kidney Injury) Therapeutic Pipeline H1 2015 Review Research Report
Financial Content 5 days ago -
Exclusive: Pfizer is once again cutting back R&D staff in reorganization
Fierce Biotech 5 days ago
